A detailed history of Black Rock Inc. transactions in Amgen Inc stock. As of the latest transaction made, Black Rock Inc. holds 47,971,073 shares of AMGN stock, worth $15 Billion. This represents 0.32% of its overall portfolio holdings.

Number of Shares
47,971,073
Previous 47,812,390 0.33%
Holding current value
$15 Billion
Previous $13.8 Billion 0.96%
% of portfolio
0.32%
Previous 0.36%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $42.7 Million - $51.5 Million
158,683 Added 0.33%
47,971,073 $13.6 Billion
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $60.7 Million - $68.5 Million
237,506 Added 0.5%
47,812,390 $13.8 Billion
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $136 Million - $169 Million
620,831 Added 1.32%
47,574,884 $12.8 Billion
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $391 Million - $463 Million
-1,826,180 Reduced 3.74%
46,954,053 $10.4 Billion
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $60 Million - $73.1 Million
265,593 Added 0.55%
48,780,233 $11.8 Billion
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $377 Million - $478 Million
1,643,932 Added 3.51%
48,514,640 $12.7 Billion
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $10.1 Million - $11.4 Million
45,156 Added 0.1%
46,870,708 $10.6 Billion
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $739 Million - $822 Million
-3,202,618 Reduced 6.4%
46,825,552 $11.4 Billion
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $3.99 Million - $4.41 Million
-18,175 Reduced 0.04%
50,028,170 $12.1 Billion
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $205 Million - $235 Million
1,032,929 Added 2.11%
50,046,345 $11.3 Billion
Q3 2021

Nov 09, 2021

BUY
$212.27 - $248.7 $252 Million - $296 Million
1,188,514 Added 2.49%
49,013,416 $10.4 Billion
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $11.2 Billion - $12.4 Billion
47,824,902 New
47,824,902 $11.7 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.